NANOSALUS Project
Therapeutic Nanomaterials with Optimized Delivery for Human Health — No. F/310152/01-02/X56.
From 23 August 2023 to 22 August 2026, the research and development project "NANOSALUS – Therapeutic Nanomaterials with Optimized Delivery for Human Health" is active, funded under the Innovation Agreement signed on 12 April 2023.
The project involves a strategic partnership with Ca' Foscari University of Venice. It is a high-tech initiative aimed at developing innovative therapeutic systems based on functionalized nanomaterials with high release (delivery) efficiency, intended for healthcare, biomedical and pharmaceutical applications.
The multidisciplinary approach and the synergy between industry and academic research are a distinctive feature of the project, which is included among the priority trajectories for competitiveness and innovation in the health and life sciences sector.
Project cost
€ 5.262.758,26
Grant
€ 2.632.336,30
Partner
Ca' Foscari University, Venice
Innovation Agreement · 2023–2026
